Growth	O
state	O
-	O
dependent	O
regulation	O
of	O
protein	O
kinase	O
C	O
in	O
normal	O
and	O
transformed	O
murine	O
cells	B-Cell
.	O

We	O
determined	O
whether	O
growth	O
state	O
can	O
influence	O
the	O
action	O
of	O
protein	O
kinase	O
C	O
by	O
measuring	O
protein	O
kinase	O
C	O
activity	O
in	O
growing	O
and	O
stationary	O
cultures	B-Cell
of	O
normal	O
and	O
transformed	O
cells	B-Cell
.	O

Two	O
approaches	O
were	O
used	O
to	O
measure	O
protein	O
kinase	O
C	O
:	O
assay	O
of	O
intact	O
cells	B-Cell
for	O
inhibition	O
of	O
epidermal	O
growth	O
factor	O
(	O
EGF	O
)	O
binding	O
in	O
response	O
to	O
phorbol	O
dibutyrate	O
(	O
PDBu	O
)	O
;	O
and	O
assay	O
of	O
detergent	O
extracts	B-Organism_substance
for	O
total	O
calcium	O
,	O
phospholipid	O
-	O
dependent	O
kinase	O
activity	O
.	O

In	O
extracts	B-Organism_substance
of	O
growing	O
and	O
stationary	O
Swiss	B-Cell
3T3	I-Cell
cells	I-Cell
,	O
the	O
total	O
amount	O
of	O
protein	O
kinase	O
C	O
activity	O
was	O
similar	O
,	O
indicating	O
that	O
growth	O
state	O
does	O
not	O
alter	O
the	O
level	O
of	O
enzyme	O
in	O
the	O
cell	B-Cell
.	O

The	O
short	O
-	O
term	O
response	O
of	O
Swiss	B-Cell
3T3	I-Cell
cells	I-Cell
to	O
an	O
activator	O
of	O
protein	O
kinase	O
C	O
also	O
appeared	O
to	O
be	O
independent	O
of	O
growth	O
state	O
,	O
since	O
the	O
50	O
%	O
effective	O
dose	O
for	O
PDBu	O
inhibition	O
of	O
EGF	O
binding	O
to	O
its	O
receptor	O
was	O
approximately	O
7	O
nM	O
for	O
both	O
growth	O
conditions	O
.	O

In	O
contrast	O
,	O
the	O
response	O
of	O
cells	B-Cell
to	O
long	O
-	O
term	O
treatment	O
with	O
PDBu	O
was	O
significantly	O
different	O
depending	O
upon	O
the	O
initial	O
growth	O
state	O
of	O
the	O
cells	B-Cell
.	O

In	O
both	O
growth	O
states	O
,	O
PDBu	O
caused	O
loss	O
of	O
protein	O
kinase	O
C	O
activity	O
,	O
which	O
reflected	O
a	O
loss	O
in	O
protein	O
mass	O
as	O
determined	O
by	O
immunoblotting	O
with	O
antiserum	B-Organism_substance
to	O
protein	O
kinase	O
C	O
.	O

However	O
,	O
the	O
maximum	O
decrease	O
approached	O
100	O
%	O
in	O
stationary	O
cultures	B-Cell
versus	O
approximately	O
75	O
%	O
in	O
growing	O
cells	B-Cell
.	O

Protein	O
kinase	O
C	O
levels	O
in	O
several	O
transformed	O
cell	B-Cell
lines	I-Cell
were	O
subject	O
to	O
down	O
modulation	O
in	O
a	O
similar	O
growth	O
state	O
-	O
dependent	O
manner	O
.	O

Further	O
,	O
the	O
inhibition	O
of	O
EGF	O
binding	O
by	O
tumor	B-Cancer
promoters	O
following	O
long	O
-	O
term	O
treatment	O
of	O
Swiss	B-Cell
3T3	I-Cell
cells	I-Cell
with	O
PDBu	O
also	O
varied	O
with	O
growth	O
state	O
.	O

In	O
down	O
modulated	O
growing	O
cells	B-Cell
,	O
PDBu	O
caused	O
almost	O
complete	O
inhibition	O
of	O
EGF	O
binding	O
,	O
whereas	O
in	O
down	O
modulated	O
stationary	O
cells	B-Cell
,	O
minimal	O
inhibition	O
of	O
EGF	O
binding	O
by	O
PDBu	O
was	O
observed	O
.	O

These	O
results	O
suggest	O
that	O
prolonged	O
treatment	O
with	O
tumor	B-Cancer
promoters	O
alters	O
the	O
sensitivity	O
of	O
cells	B-Cell
to	O
activators	O
of	O
protein	O
kinase	O
C	O
in	O
a	O
growth	O
state	O
-	O
dependent	O
manner	O
.	O

